Investigative Urology - Results from #4560

Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth- Abstract March 6, 2013

Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients- Abstract March 6, 2013

Endothelial-rich microenvironment supports growth and branching morphogenesis of prostate epithelial cells - Abstract March 6, 2013

The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence- Abstract March 6, 2013

Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer - investigation of a correlation with Gleason score- Abstract March 6, 2013

Definition of molecular determinants of prostate cancer cell bone extravasation - Abstract March 5, 2013

Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: Correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis - Abstract March 5, 2013

Distinct epigenetic mechanisms distinguishTMPRSS2-ERG fusion-positive and -negative prostate cancers - Abstract March 5, 2013

Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis - Abstract March 5, 2013

MicroRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications and AKT pathways - Abstract March 5, 2013

First synthesis of (+)-myrrhanol C, an anti-prostate cancer lead - Abstract March 5, 2013

Efficient multicistronic co-expression of hNIS and hTPO in prostate cancer cells for nonthyroidal tumor radioiodine therapy - Abstract March 5, 2013

Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness - Abstract March 4, 2013

Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases- Abstract March 2, 2013

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer- Abstract March 1, 2013

Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder- Abstract March 1, 2013

CLT1 targets bladder cancer through integrin α5β1 and CLIC3- Abstract March 1, 2013

Targeting folate receptors to treat invasive urinary bladder cancer- Abstract March 1, 2013

Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer- Abstract March 1, 2013

Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer- Abstract March 1, 2013

Page 229 of 346